Masayoshi Son, SoftBank CEO (glen photo/Shutterstock)
Japan's SoftBank plots billions in biotech investments in move that could keep the valuation flood rising — report
The valuation crazy train in biotech continues to roll into the new year with more than a dozen companies taking a chance on Nasdaq and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
